Retrospective study on the impact of hepatitis C virus infection on kidney transplant patients over 20 years

Transplantation

Volumn 66, Issue 4, 1998, Pages 471-476

  Hanafusa, Touru ^a   Ichikawa, Yasuji ^a   Kishikawa, Hidefumi ^a   Kyo, Masahiro ^a   Fukunishi, Takanobu ^a   Kokado, Yukito ^b   Okuyama, Akihiko ^b   Shinji, Yoshitake ^a   Nagano, Shunsuke ^a  

^a Hyogo Prefectural Nishinomiya Hospital   (Japan)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; AZATHIOPRINE; CYCLOSPORIN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; RECOMBINANT ALPHA2A INTERFERON; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SURVIVAL RATE;

ADULT; FEMALE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; INTERFERON-ALPHA; KIDNEY TRANSPLANTATION; MALE; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; SURVIVAL RATE;

EID: 0032572688     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00010     Document Type: Article

References (24)

1. Huang C-C, Liaw Y-F, Lai M-K, Chu S-H, Chuang C-K, Huang J-Y. The clinical outcome of hepatitis C virus antibody-positive renal allograft recipients. Transplantation 1992; 53: 763.
2. Brunson ME, Lau JY-N, Davis GL, Scornik J, Howard RJ, Pfaff WW. Non-A, non-B hepatitis and elevated serum aminotransferases in renal transplant patients. Transplantation 1993; 56: 1364.
3. Kiyosawa K, Sodeyama T, Tanaka E, et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671.
4. Pereira BJG, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 799.
5. Roth D, Fernandez JA, Burke GW, Esquenazi V, Miller J. Detection of antibody to hepatitis C virus in renal transplant recipients. Transplantation 1991; 51: 396.
6. Thervet E, Pol S, Legendre CH, Gagnadoux M-F, Cavalcanti R, Kreis H. Low-dose recombinant interferon-α treatment of hepatitis C viral infection in renal transplant recipients: a pilot study. Transplantation 1994; 58: 625.
7. Magnone M, Holley JL, Shapiro R, et al. Interferon-α induced acute renal allograft rejection. Transplantation 1995; 59: 1068.
8. Fujimoto N, Kyo M, Ichikawa Y, Fukunishi T, Nagano S. The impact of hepatitis C virus infection on liver disease in renal transplant recipients. Transplant Int 1994; 7: S346.
9. Okamoto H, Sugiyama Y, Okada S, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992; 73: 673.
10. Kato N, Yokosuka O, Hosoda K, Ito Y, Ohta M, Omata M. Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advance liver disease. Hepatology 1993; 18: 16.
11. Hagiwara H, Hayashi N, Mita E, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993; 104: 877.
12. Katzka DA, Saul SH, Jorkasky D, Sigal H, Reynolds JC, Soloway RD. Azathioprine and hepatic venoocclusive disease in renal transplant patients. Gastroenterology 1986; 90: 446.
13. Cavalcanti R, Pol S, Carnot F, et al. Impact and evolution of peliosis hepatis in renal transplant recipients. Transplantation 1994; 58: 315.
14. Choo Ql, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359.
15. Kuo G, Choo Q-L, Alter HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362.
16. Izumi S, Nishiuchi M, Kameda Y, et al. Laparoscopic study of peliosis hepatis and nodular transformation of the liver before and after renal transplantation: natural history and aetiology in follow-up cases. J Hepatol 1994; 20: 129.
17. Pol S, Cavalcanti R, Carnot F, et al. Azathioprine hepatitis in kidney transplant recipients. Transplantation 1996; 61: 1774.
18. Kliem V, Hoff UVD, Brunkhorst R, et al. The long-term course of hepatitis C after kidney transplantation. Transplantation 1996; 62: 1417.
19. Rao KV, Andersen RC. Long-term results and complications in renal transplant recipients: observations in the second decade. Transplantation 1988; 45: 45.
20. Ichikawa Y, Kyo M, Hanafusa T, et al. A 20-year case study of a kidney transplant recipient with chronic active hepatitis C. Transplantation 1998; 65: 134.
21. Ichimaru K, Tanaka T, Muramoto Y, Amagase H. Hepatitis-C and its potential transmission without blood transfusion in patients on maintenance hemodialysis. Jpn J Soc Dialysis Ther 1995; 28: 1245.
22. Kanai K, Kako M, Okamoto H. HCV genotypes in chronic hepatitis C and response to interferon. Lancet 1992; 339: 1543.
23. Rostaing L, Izopet J, Baron E, Duffaut M, Puel J, Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 1995; 59: 1426.
24. Japanese Red Cross Non-A, Non-B Hepatitis Research Group. Effect of screening for hepatitis C antibody and hepatitis B virus core antibody on incidence of post-transfusion hepatitis. Lancet 1991; 338: 1040.